| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.095 | 0.7 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |